Cite
HARVARD Citation
Gordon, P. et al. (n.d.). AB0629 Design of A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial of The Toll-like Receptor Antagonist IMO-8400 in Patients with Dermatomyositis. Annals of the rheumatic diseases. p. 1119. [Online].